Filing Details
- Accession Number:
- 0001209191-10-023882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-27 13:00:00
- Reporting Period:
- 2010-04-23
- Filing Date:
- 2010-04-27
- Accepted Time:
- 2010-04-27 17:20:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1357396 | George Spiro Rombotis | 200 Connell Drive Suite 1500 Berkeley Heights NJ 07922 | President & C.e.o. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Disposition | 2010-04-23 | 8,350 | $2.50 | 483,198 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Rombotis.
- Of the shares of common stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account and 32,290 shares are represented by unvested restricted stock units.